Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2025
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Benjamin G. S. Fowke [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On May 15, 2025, Benjamin G. S. Fowke, III, a director of the Company, entered into a Rule 10b5-1 trading agreement (“Rule 10b5-1 Trading Plan”) intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) of the Securities Exchange Act of 1934. Mr. Fowke’s Rule 10b5-1 Trading Plan provides for an aggregate sale of up to 25,000 shares of common stock through December 12, 2025.
|
| Name | Benjamin G. S. Fowke |
| Title | a director of the Company |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | May 15, 2025 |
| Expiration Date | December 12, 2025 |
| Arrangement Duration | 211 days |
| Aggregate Available | 25,000 |
| Kelly J. Ferneau [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On May 15, 2025, Kelly J. Ferneau, the Executive Vice President and Chief Nuclear Officer of the Company, entered into a Rule 10b5-1 Trading Plan intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) of the Securities Exchange Act of 1934. Ms. Ferneau’s Rule 10b5-1 Trading Plan provides for an aggregate sale of up to 10,218 shares of common stock through February 23, 2026.
|
| Name | Kelly J. Ferneau |
| Title | Executive Vice President and Chief Nuclear Officer of the Company |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | May 15, 2025 |
| Expiration Date | February 23, 2026 |
| Arrangement Duration | 284 days |
| Aggregate Available | 10,218 |